Thrivent Financial for Lutherans Raises Position in Xylem Inc. $XYL

Thrivent Financial for Lutherans grew its stake in Xylem Inc. (NYSE:XYL) by 378.2% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 47,670 shares of the industrial products company’s stock after purchasing an additional 37,701 shares during the period. Thrivent Financial for Lutherans’ holdings in Xylem were worth $6,166,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the stock. Maseco LLP bought a new stake in Xylem in the second quarter worth $31,000. ST Germain D J Co. Inc. boosted its stake in shares of Xylem by 950.0% during the 2nd quarter. ST Germain D J Co. Inc. now owns 252 shares of the industrial products company’s stock worth $33,000 after purchasing an additional 228 shares during the period. Signature Resources Capital Management LLC purchased a new position in shares of Xylem during the 2nd quarter worth about $39,000. FWL Investment Management LLC bought a new position in Xylem during the 2nd quarter valued at about $43,000. Finally, Financial Gravity Companies Inc. purchased a new stake in Xylem in the 2nd quarter worth about $44,000. Institutional investors own 87.96% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently commented on XYL. Mizuho set a $160.00 target price on Xylem in a research note on Wednesday, October 29th. Cowen restated a “hold” rating on shares of Xylem in a report on Friday, December 5th. TD Cowen increased their target price on Xylem from $130.00 to $135.00 and gave the stock a “hold” rating in a research note on Friday, December 5th. Weiss Ratings reissued a “buy (b)” rating on shares of Xylem in a research note on Monday. Finally, Stifel Nicolaus raised their price target on shares of Xylem from $175.00 to $178.00 and gave the stock a “buy” rating in a research note on Wednesday, October 29th. Eight equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $167.40.

Xylem Price Performance

XYL opened at $138.04 on Friday. The company has a market capitalization of $33.61 billion, a price-to-earnings ratio of 35.49, a PEG ratio of 2.12 and a beta of 1.18. The company has a current ratio of 1.96, a quick ratio of 1.50 and a debt-to-equity ratio of 0.17. Xylem Inc. has a 12-month low of $100.47 and a 12-month high of $154.27. The business’s fifty day simple moving average is $143.90 and its 200-day simple moving average is $139.36.

Xylem (NYSE:XYL) last released its quarterly earnings data on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share for the quarter, topping analysts’ consensus estimates of $1.23 by $0.14. The company had revenue of $2.27 billion during the quarter, compared to analyst estimates of $2.22 billion. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The firm’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.11 earnings per share. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. On average, equities research analysts anticipate that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 23rd. Investors of record on Tuesday, November 25th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend is Tuesday, November 25th. Xylem’s dividend payout ratio (DPR) is presently 41.13%.

Insider Buying and Selling

In other Xylem news, EVP Claudia S. Toussaint sold 10,421 shares of the company’s stock in a transaction on Thursday, October 30th. The stock was sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the completion of the sale, the executive vice president owned 31,250 shares in the company, valued at $4,770,000. This represents a 25.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Victoria D. Harker sold 1,700 shares of the stock in a transaction on Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total value of $251,838.00. Following the sale, the director directly owned 16,875 shares in the company, valued at $2,499,862.50. This trade represents a 9.15% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.27% of the company’s stock.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.